Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Related Citations for PubMed (Select 48646)

1.

Letter: 1-18 Corticotrophin and allergy to tetracosactrin-depot.

Brombacher PJ, Maesen FP, Gijzen AH.

Lancet. 1975 Feb 22;1(7904):456. No abstract available.

PMID:
48646
2.

[Adverse effects of synthetic ACTH (tetracosactide-Zn)--asthmatic attack and shock-report of 2 cases].

Kawai M, Maekawa N.

Nihon Kyobu Shikkan Gakkai Zasshi. 1975 Nov;13(11):663-70. Japanese. No abstract available.

PMID:
176495
4.
5.

Letter: Allergic reactions to tetracosactrin.

Mohr PD.

Br Med J. 1975 Oct 18;4(5989):162. No abstract available.

6.

[Severe bronchial obstruction as a reaction to the administration of the tetracosactides depot-Cortrosyn and depot-Synacthen].

Roldaan AC, de Jong C.

Ned Tijdschr Geneeskd. 1981 Feb 21;125(8):321-3. Dutch. No abstract available.

PMID:
6261167
7.

[Tetracosactide (Synacthen Depot) in patients with multiple sclerosis].

Kanić M, Sepcić J.

Lijec Vjesn. 1992 May-Aug;114(5-8):134-6. Croatian.

PMID:
1343045
8.

Adverse reactions to Zn1-24 ACTH therapy associated with specific cellular immunity.

Glass D, Roffe L, Maini RN, Wraith DG, Nuki G.

Clin Exp Immunol. 1975 Apr;20(1):55-63.

9.

Allergy to tetracosactrin-depot.

Partiarca G.

Lancet. 1971 Jan 16;1(7690):138. No abstract available.

PMID:
4099629
10.

[Experiences with depot-ACTH (Tetracosactide) in bronchial obstruction].

Kropp R.

Fortschr Med. 1976 Mar 4;94(7):395-8. German.

PMID:
184022
11.

Hypersensitivity to different ACTH peptides.

Forssman O, Mulder J.

Acta Med Scand. 1973 Jun;193(6):557-9. No abstract available.

PMID:
4352856
12.

Measurement of the adrenal cortex reserve using depot beta 1-24-corticotrophin. II---in thyroid diseases.

Galvão-Teles A.

Acta Med Port. 1979 May-Jun;1(3):315-24. No abstract available.

13.

Evaluation and management of corticotropin allergy.

Lee TM, Grammer LC, Shaughnessy MA, Patterson R.

J Allergy Clin Immunol. 1987 Jun;79(6):964-8.

PMID:
3034995
14.

A synthetic polypeptide--beta 1-24 corticotropin--in the depot form. II. Clinical efficacy of intermittent therapy in asthmatic patients.

Benos SA, Koutsoukos A, Sotirakis I, Pavlatos FC.

Acta Allergol. 1969 Sep;24(3):178-86. No abstract available.

PMID:
4314190
15.

[Effect of intravenous hydrocortisone and intramuscular ACTH on spirometric indicators in patients with partially reversible bronchial stenosis].

Müller J, Radomyski A, Vertun-Baranowska B, Styszewsko H.

Pneumonol Pol. 1987 Jan;55(1):26-33. Polish. No abstract available.

PMID:
3035512
16.

[Long-term Cortrosyn-depot therapy of steroid-dependent patients suffering from bronchial asthma].

Rott Z, Fajt E, Tóth S, Hammer I, Nagy G.

Orv Hetil. 1983 Jul 31;124(31):1883-6. Hungarian. No abstract available.

PMID:
6314223
17.

[Use of Cortrosyn Depot in dermatology].

Aussems J.

Brux Med. 1976 Jan;56(1):15-20. French. No abstract available.

PMID:
175889
18.
19.

[Spastic flexion disorders: clinical and metabolic problems observed during treatment with zinc tetracosactide].

Cret L, David M, Macabéo V, Frédérich A, Jeune M.

Pediatrie. 1976 Jan-Feb;31(1):33-48. French. No abstract available.

PMID:
184427
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk